Approximately 2 weeks after a 6f low profile plastic bioflo vortex port implantation, the patient began experiencing symptoms of an infection along the port tract and in their neck.The patient was placed on an antibiotic treatment and seemed to improve; however, once the round of antibiotics was completed, the patient developed a fever.A different antibiotic was prescribed and the decision was made to remove the port.Cultures of the port pocket were negative and the port had not yet been used for treatment.
|
Returned for evaluation was one (1) port sample with catheter tubing attached.As received, the septum was filled with bio-material {blood}.Approximately 38cm of catheter tubing was attached to the port sample.No other defects were noted to the returned port sample.The customer's reported complaint description of patient infection cannot be confirmed given the patient centric nature of this serious adverse event (sae).There was no report of port/catheter device malfunction, damage or performance issue during use, however, device was returned for evaluation.No manufacturing non-conformances were observed during sample evaluation and device met product specifications.Dhr review of the indicated packaging/assembly/catheter lots revealed no quality related issues or manufacturing deficiencies at the time of manufacture.Incoming inspection records for catheter tubing lal bacterial endotoxin testing results and sterilization load release records for packaging lot 5772539 were reviewed, no issues observed.Labeling review: the directions for use (dfu) that is provided in the reported kit contains the following directions and precautions: contraindications: catheter insertion in the subclavian vein medial to the border of the first rib, an area which is associated with higher rates for pinch-off.Warnings: do not use syringes smaller than 10 ml syringe when accessing the port as system damage can occur.Flushing occluded catheters with small syringes can create excessive pressures within the port system.Do not forcefully flush the port system with any syringe size.After confirmation of patency by detecting no resistance and the presence of a blood return, use syringes appropriately sized for the medication being injected.Do not transfer the medication to a larger syringe.Failure to ensure patency of the catheter prior to power injection studies may result in port system failure and patient injury may occur.Do not power inject through a port system that exhibits signs of clavicle-first rib compression or pinch-off as it may result in port system failure and patient injury may occur.Absence of a blood return or a poor blood return can be a sign of a potential complication such as occlusion, kinking, breakage, pinch-off syndrome, fibrin formation, thrombosis or malposition.This should be evaluated prior to device usage.A blood return should be present prior to usage of device for any therapy or testing.Do not attempt to measure the patient's blood pressure on the arm in which a peripheral system is located, since catheter occlusion or other damage to the catheter could occur.If the patient complains of pain, or there is swelling when the device is flushed or when medication or contrast media is administered, evaluate the device for infiltration, proper needle placement, and potential complications such as occlusion, kinking, breakage, pinch-off syndrome, thrombosis or malposition.Failure to assess these complaints or observations can lead to device failure.Precautions: to avert device damage and/or patient injury during catheter placement: avoid accidental device contact with sharp instruments and mechanical damage to the catheter material.Use only smooth-edged atraumatic clamps or forceps.Do not use the catheter if there is any evidence of mechanical damage or leaking.Avoid sharp or acute angles during implantation which could compromise the patency of the catheter lumen.Carefully follow the catheter to port connection technique provided in the dfu to ensure proper device connection and to avoid catheter damage.Assure tight connection between port body and catheter.After implantation or any treatment via the port, the system should be flushed with normal saline for injection per institutional protocol.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
|